Alzheimer's amyloid β-peptide associated free radicals increase rat embryonic neuronal polyamine uptake and ornithine decarboxylase activity: Protective effect of vitamin E

Neuroscience Letters

Volumn 263, Issue 1, 1999, Pages 17-20

  Yatin, Servet M ^a   Yatin, Mustafa ^b,c   Aulick, Timothy ^a   Ain, Kenneth B ^b,c   Butterfield, D Allan ^a,d  

^a UNIVERSITY OF KENTUCKY   (United States)

^b LEXINGTON VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alzheimer's disease; Amyloid peptide; Free radicals; Ornithine decarboxylase activity; Polyamine uptake; Spermidine; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; FREE RADICAL; ORNITHINE DECARBOXYLASE; POLYAMINE; SPERMIDINE;

ALZHEIMER DISEASE; AMINE TRANSPORT; ANIMAL CELL; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; EMBRYO; FETUS; HIPPOCAMPUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

AMYLOID BETA-PROTEIN; ANIMALS; BIOLOGICAL TRANSPORT; CELL SURVIVAL; CELLS, CULTURED; ELECTRON SPIN RESONANCE SPECTROSCOPY; FETUS; FREE RADICALS; HIPPOCAMPUS; NEURONS; ORNITHINE DECARBOXYLASE; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; SPERMIDINE; VITAMIN E;

EID: 0033583252     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00101-9     Document Type: Article

References (24)

1. Aziz S.M., Yatin M., Worthen D.R., Lipke D.W., Crooks P.A. A novel technique for visualizing the intracellular localization and distribution of transported polyamines in cultured pulmonary artery smooth muscle cells. J. Pharm. Biomed. Anal. 2:1998;307-320.
2. Behl C., Davis J.B., Lesley R., Shubert D. Hydrogen peroxide medicates amyloid β protein toxicity. Cell. 77:1994;817-827.
3. Bernstein H.G., Muller M. Increased immunostaining for L-ornithine decarboxylase occurs in neocortical neurons of Alzheimer's disease patients. Neurosci. Lett. 186:1995;123-126.
4. Butterfield D.A., Hensley K., Harris M., Mattson M.P., Carney J.M. β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's Disease. Biochem. Biophys. Res. Commun. 200:1994;710-715.
5. Butterfield D.A. β-Amyloid-generated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease. Chem. Res. Toxicol. 10:1997;518-526.
6. Brewer G.J., Torricelli J.R., Evege E.K., Price P.J. Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J. Neurosci. Res. 35:1993;567-576.
7. Dienel G.A., Cruz N.F. Induction of brain ornithine decarboxylase during recovery from metabolic, mechanical, thermal, or chemical injury. J. Neurochem. 42:1984;1053-1062.
8. Gilad G.M., Gilad V.H. Polyamines in neurotrauma: ubiquitous molecules in search of a function. Biochem. Pharm. 44:1992;401-407.
9. Greenamyre J.T., Young A.B. Excitatory amino acids and Alzheimer's disease. Neurobiol. Aging. 10:1989;593-602.
10. Harris M.E., Hensley K., Butterfield D.A., Leedle R.A., Carney J.M. Direct evidence of oxidative injury produced by the Alzheimer's amyloid beta protein (1-40) in cultured hippocampal neurons. Exp. Neurol. 132:1995;193-202.
11. Hayashi S.I., Murakami Y. Rapid and regulated degradation of ornithine decarboxylase. Biochem. J. 306:1995;1-10.
12. Hensley K., Carney J.M., Mattson M.P., Aksenova M., Harris M., Wu J.F., Floyd R.A., Butterfield D.A. A model for β-amyloid aggregation and neurotoxicity based on free radical generated by the peptide: Relevance to Alzheimer disease. Proc. Natl. Acad. Sci. USA. 91:1994;3270-3274.
13. Lipton S.A., Rosenberg P.A. Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330:1994;613-622.
14. Lopatin A.N., Makhina E.N., Nichols C.G. Potassium channel block by cytoplasmic polyamines as the mechanism of intrinsic rectification. Nature. 372:1994;366-369.
15. Marton L.J., Pegg A.E. Polyamines as targets for therapeutic intervention. Annu. Rev. Pharmacol. Toxicol. 35:1995;55-91.
16. Morgan, D.M., Polyamine Protocols, Humana Press, Totowa, NJ, 1998, pp. 1-183.
17. Morrison L.D., Cao X.C., Kish S.J. Ornithine decorboxylase in human brain: influence of aging, regional distribution, and Alzheimer's disease. J. Neurochem. 71:1998;288-294.
18. Russell D., Snyder S.H. Amine synthesis in rapidly growing tissues: ornithine decarboxylase activity in regenerating rat liver chick embryos and various tumors. Proc. Natl. Acad. Sci. USA. 60:1968;1420-1427.
19. Saito K., Packianathan S., Longo L.D. Free radical-induced elevation of ornithine decarboxylase activity in developing rat brain slices. Brain Res. 763:1997;232-238.
20. Sano M., Ernesto C., Thomas R.G., Klauber M.R., Schafer K., Grundman M., Woodbury P., Growdon J., Cotman C.W., Pfeiffer E., Schneider L.S., Thal L.J. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease: the Alzheimer's Disease Cooperative Study. N. Engl. J. Med. 336:1997;1216.
21. Seidl R., Beninati S., Cairns N., Singleval N., Risser D., Bavon H., Nemethov M., Lubec G. Polyamines in frontal cortex of patients with Down's syndrome and Alzheimer's disease. Neurosci. Lett. 206:1996;193-195.
22. Seiler N., Delcros J.G., Moulinous J.P. Polyamine transport in mammalian cells: an update. Int. J. Biochem. Cell Biol. 8:1996;843-861.
23. Selkoe D.J. Amyloid β-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271:1996;18295-18298.
24. Yatin S.M., Aksenov M., Butterfield D.A. The antioxidant vitamin E modulates amyloid β-peptide-induced creatine kinase activity inhibition and increased protein oxidation: implications for the free radical hypothesis of Alzheimer's disease. Neurochem. Res. 24:1999;427-435.